Analyst forecasts YoY quarterly growth for Coloplast following virus year
![Photo: Coloplast / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13204648.ece/ALTERNATES/schema-16_9/doc7h4f2iqzjco1mqpwlmht.jpg)
Upon presenting its third-quarter statement for staggered fiscal year 2020-'21, Danish medical technology company Coloplast is expected to announce growth driven by improved market conditions tied to improved patient access following societies opening back up from pandemic lockdowns, says Senior Analyst Søren Løntoft Hansen from Denmark's Sydbank.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Coloplast sees potential in Russia
For subscribers